Guthrie C M, Banting S W, Garden O J, Carter D C
University Department of Surgery, Royal Infirmary, Edinburgh, UK.
Br J Surg. 1994 Nov;81(11):1639-41. doi: 10.1002/bjs.1800811125.
Between 1984 and 1992, 26 patients with obstructive jaundice due to malignancy at the liver hilum were treated by segment III Roux-en-Y cholangiojejunostomy. Twenty-two patients had hilar cholangiocarcinoma, one carcinoma of the gallbladder, one pancreatic carcinoma, one recurrent gastric carcinoma and one lymphoma. Seventeen patients had no complications in the postoperative period and six had complications; there were three postoperative deaths. Eighteen of the 23 surviving patients experienced complete resolution of jaundice for at least 3 months. Four developed recurrent jaundice and three had episodes of cholangitis before death. Segment III cholangiojejunostomy offers effective palliation for most patients with irresectable hilar malignancy.
1984年至1992年间，26例因肝门部恶性肿瘤导致梗阻性黄疸的患者接受了Ⅲ段Roux-en-Y胆管空肠吻合术治疗。22例为肝门部胆管癌，1例为胆囊癌，1例为胰腺癌，1例为复发性胃癌，1例为淋巴瘤。17例患者术后无并发症，6例出现并发症；术后死亡3例。23例存活患者中有18例黄疸完全消退至少3个月。4例出现复发性黄疸，3例在死亡前发生胆管炎发作。Ⅲ段胆管空肠吻合术为大多数无法切除的肝门部恶性肿瘤患者提供了有效的姑息治疗。
